Mortality Rates for Pneumonia and Influenza Vary by Geographical Area
Researchers assessed whether there was geographic variation in racial disparity in influenza and pneumonia.
Influenza
Nosocomial Influenza Outbreak Investigation Informed by Genomic Analyses
Investigators used precision surveillance by combining genomic sequencing and conventional surveillance to delineate a nosocomial viral outbreak; they believe the findings of their study are applicable to a range of respiratory pathogens, including SARS-CoV-2.
Either Trivalent Flu Vaccine Safe for Use in Older Adults
Either the trivalent adjuvanted inactivated influenza vaccine (aIIV3) or the trivalent high-dose inactivated influenza vaccine (HD-IIV3) is safe to use in older adults.
Neutrophilic Inflammation, Immunothrombosis May Distinguish Severe COVID-19 From Influenza
Severe coronavirus disease 2019 (COVID-19) is associated with immunothrombotic, neutrophil-containing vessel occlusions in the lung.
High-Dose Trivalent Flu Shot No Better for Patients With CVD
For patients with high-risk CVD, high-dose trivalent inactivated influenza vaccination does not reduce cardiopulmonary hospitalization or all-cause mortality.
Symptom-Based Case Definitions for Detecting Influenza in Pregnant Women
Study authors evaluated the performance of symptom-based definitions to detect influenza in a cohort of pregnant women in India, Peru, and Thailand.
Flu Shot More Popular Than COVID-19 Vaccine Among Older Adults
Older adults are less likely to get a COVID-19 vaccine than a flu vaccine, according to the University of Michigan National Poll on Healthy Aging.
Top November 2020 FDA Approvals
Several previously FDA-approved medicines were approved for additional uses in November 2020.
Influenza Vaccination Does Not Increase Risk for Guillain-Barré Syndrome
Study authors identified and evaluated a statistical signal for an increased risk of Guillain-Barré Syndrome in days 1-42 after 2018-2019 high-dose influenza vaccine administration.
2018 to 2019 Vaccine Cut Influenza A-Linked Hospitalizations
The 2018 to 2019 influenza vaccine effectiveness was about 40% to 60% for reducing pediatric influenza A-associated hospitalizations.
-
Loading...
-
Loading...
Next post in Vaccine Information Center
